These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11382731)

  • 1. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
    Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
    Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
    Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
    Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
    Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
    Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
    J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits.
    Aragane K; Fujinami K; Kojima K; Kusunoki J
    J Lipid Res; 2001 Apr; 42(4):480-8. PubMed ID: 11290819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H; Doi T
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
    Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
    Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
    Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of F-1394, an acyl-CoA:cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits.
    Aragane K; Kojima K; Fujinami K; Kamei J; Kusunoki J
    Atherosclerosis; 2001 Sep; 158(1):139-45. PubMed ID: 11500184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
    Leon C; Hill JS; Wasan KM
    Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
    Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
    Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
    Kusunoki J; Aragane K; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.
    Fazio S; Major AS; Swift LL; Gleaves LA; Accad M; Linton MF; Farese RV
    J Clin Invest; 2001 Jan; 107(2):163-71. PubMed ID: 11160132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.
    Chandak PG; Obrowsky S; Radovic B; Doddapattar P; Aflaki E; Kratzer A; Doshi LS; Povoden S; Ahammer H; Hoefler G; Levak-Frank S; Kratky D
    Biochim Biophys Acta; 2011 Dec; 1811(12):1011-20. PubMed ID: 21924378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in apoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT).
    Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Horlad H; Ikeda T; Nohara T; Takeya M; Nagai R
    J Agric Food Chem; 2012 Mar; 60(10):2472-9. PubMed ID: 22224814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein secretion.
    Aragane K; Kusunoki J; Kitamine T; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1998 Mar; 76(3):309-12. PubMed ID: 9593225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.
    Namatame I; Tomoda H; Ishibashi S; Omura S
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):737-42. PubMed ID: 14718664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.